Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03004053 · ClinicalTrials.gov registry record

Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In Vivo

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
23
Enrollment target

NCT03004053: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT03004053 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03004053 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
23 participants
Enrollment target

Study Summary

The purpose of this study is to obtain images (pictures) of normal oral tissue, which occur inside the mouth, using a special camera. These pictures will be used in our research to evaluate a new technology that uses a laser and takes pictures of the microscopic structure of tissue. The technology is called "reflectance confocal microscopy."

Interventions

  • DEVICE Reflectance Confocal Microscopy (RCM) endoscope device

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2016-12
Est. Completion 2022-02-28

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT03004053

The ClinicalTrials.gov registry entry for NCT03004053 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Reflectance Confocal Microscopy (RCM) endoscope device is the first listed.

NCT03004053 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03004053 about?

NCT03004053 is a clinical study titled "Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In Vivo". The purpose of this study is to obtain images (pictures) of normal oral tissue, which occur inside the mouth, using a special camera. These pictures will be used in our research to evaluate a new technology that uses a laser and takes pictures of the microscopic structure of tissue. The technology i...

What is the current status of trial NCT03004053?

This trial is currently completed. The enrollment target is 23 participants. The study started on 2016-12. Estimated completion is 2022-02-28.

What interventions are being tested in trial NCT03004053?

The interventions under investigation include: Reflectance Confocal Microscopy (RCM) endoscope device (DEVICE).

Who is sponsoring clinical trial NCT03004053?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.